Patents Assigned to ProteaDX, Inc.
  • Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems
    Patent number: 10321858
    Abstract: Provided are transdermal microneedle-based devices for sensing the presence and concentration of analytes such as electrolytes, biomarkers, drugs, and proteins in interstitial fluid. Also provided are methods and systems to transmit the data obtained by wired or wireless connection to a receiver and to relay the data to the user or a clinician.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: June 18, 2019
    Assignee: ProteaDX, Inc.
    Inventors: Jose Antonio Maiz-Aguinaga, Lennart Olsson